The evolving field of kinase inhibitors in thyroid cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference138 articles.
1. Increasing incidence of thyroid cancer in the United States, 1973–2002;Davies;JAMA,2006
2. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype – papillary, follicular, and anaplastic: a morphological and epidemiological study;Albores-Saavedra;Endocr Pathol,2007
3. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors;Ye;Endocr Rev,2010
4. Cytotoxic chemotherapy for differentiated thyroid carcinoma;Sherman;Clin Oncol (R Coll Radiol),2010
5. Papillary and follicular thyroid carcinoma;Schlumberger;N Engl J Med,1998
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review;Cancers;2023-03-08
2. Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways;International Journal of Molecular Sciences;2023-02-08
3. Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management;Cancers;2022-10-31
4. Alginate-based 3D cell culture technique to evaluate the half-maximal inhibitory concentration: an in vitro model of anticancer drug study for anaplastic thyroid carcinoma;Thyroid Research;2021-12
5. MAPK Inhibition Requires Active RAC1 Signaling to Effectively Improve Iodide Uptake by Thyroid Follicular Cells;Cancers;2021-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3